| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SH3 domain binding | 2.36e-05 | 143 | 80 | 6 | GO:0017124 | |
| GeneOntologyMolecularFunction | transcription factor binding | CEBPA MED25 KLF14 MED14 PER1 DAZAP2 HES1 NR1H2 ZFPM1 SUFU TRIB1 RXRB | 4.34e-05 | 753 | 80 | 12 | GO:0008134 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | SPTBN4 ZXDC BCL9L CITED4 AP2A2 VAMP2 MED14 STAP2 SYN1 SMARCC2 ZFPM1 ATG2A SUFU SHANK3 RXRB | 4.97e-05 | 1160 | 80 | 15 | GO:0030674 |
| GeneOntologyMolecularFunction | cytoskeletal protein-membrane anchor activity | 9.46e-05 | 4 | 80 | 2 | GO:0106006 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.08e-04 | 582 | 80 | 10 | GO:0140297 | |
| GeneOntologyMolecularFunction | protein domain specific binding | ZXDC CEBPA WIPF1 AP2A2 WASF2 DAZAP2 HES1 ARHGAP27 BCAR1 CNTROB UVRAG SHANK3 | 1.80e-04 | 875 | 80 | 12 | GO:0019904 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 2.64e-04 | 417 | 80 | 8 | GO:0061629 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | SPTBN4 ZXDC BCL9L CITED4 AP2A2 VAMP2 MED14 STAP2 SYN1 SMARCC2 ZFPM1 ATG2A SUFU SHANK3 RXRB | 2.81e-04 | 1356 | 80 | 15 | GO:0060090 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | FOXP4 NEUROD2 CEBPA NKX2-4 KLF14 PER1 TPRX1 IRF5 HES1 NR1H2 ARID3C RXRB FOXD1 KLF2 | 3.88e-04 | 1244 | 80 | 14 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | FOXP4 NEUROD2 CEBPA NKX2-4 KLF14 PER1 TPRX1 IRF5 HES1 NR1H2 ARID3C RXRB FOXD1 KLF2 | 4.81e-04 | 1271 | 80 | 14 | GO:0000987 |
| GeneOntologyMolecularFunction | chromatin DNA binding | 5.59e-04 | 167 | 80 | 5 | GO:0031490 | |
| GeneOntologyMolecularFunction | chromatin binding | TRIM33 CEBPA KLF14 PER1 SMARCC2 HES1 NR1H2 ARID3C CRAMP1 RXRB | 7.20e-04 | 739 | 80 | 10 | GO:0003682 |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 7.78e-04 | 45 | 80 | 3 | GO:0043495 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | FOXP4 NEUROD2 CEBPA NKX2-4 KLF14 TPRX1 IRF5 HES1 NR1H2 ARID3C ZBED3 RXRB FOXD1 KLF2 | 1.34e-03 | 1412 | 80 | 14 | GO:0000981 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.36e-03 | 303 | 80 | 6 | GO:0003713 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 1.40e-03 | 55 | 80 | 3 | GO:0042974 | |
| GeneOntologyMolecularFunction | phospholipid binding | 1.57e-03 | 548 | 80 | 8 | GO:0005543 | |
| GeneOntologyMolecularFunction | kinase binding | CEBPA AP2A2 PER1 SYN1 KCNQ1 DAZAP2 IRF5 HES1 BCAR1 SUFU TRIB1 | 1.62e-03 | 969 | 80 | 11 | GO:0019900 |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 1.69e-03 | 316 | 80 | 6 | GO:0035091 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | FOXP4 NEUROD2 CEBPA NKX2-4 KLF14 PER1 TPRX1 IRF5 HES1 NR1H2 ARID3C RXRB FOXD1 KLF2 | 1.83e-03 | 1459 | 80 | 14 | GO:0000977 |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.84e-03 | 562 | 80 | 8 | GO:0003712 | |
| GeneOntologyMolecularFunction | E-box binding | 1.89e-03 | 61 | 80 | 3 | GO:0070888 | |
| GeneOntologyMolecularFunction | nuclear vitamin D receptor binding | 2.33e-03 | 18 | 80 | 2 | GO:0042809 | |
| GeneOntologyMolecularFunction | actin binding | 3.08e-03 | 479 | 80 | 7 | GO:0003779 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 3.80e-03 | 23 | 80 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase binding | 4.13e-03 | 24 | 80 | 2 | GO:0120283 | |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 4.13e-03 | 24 | 80 | 2 | GO:0008093 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | SPTBN4 WASL GPAA1 REEP1 WIPF1 TPRN WASF2 VAMP2 SYN1 EML3 SHANK3 | 4.28e-03 | 1099 | 80 | 11 | GO:0008092 |
| GeneOntologyMolecularFunction | protein kinase A regulatory subunit binding | 4.48e-03 | 25 | 80 | 2 | GO:0034237 | |
| GeneOntologyMolecularFunction | delayed rectifier potassium channel activity | 5.60e-03 | 28 | 80 | 2 | GO:0005251 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | HJV BCL9L WASL NEUROD2 CEBPA MED25 KLF14 MED14 PER1 IRF5 HES1 NR1H2 ZFPM1 ARID3C ZBED3 RXRB FOXD1 KLF2 | 3.92e-06 | 1390 | 79 | 18 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | HJV TRIM33 FOXP4 CEBPA MED25 PER1 SMARCC2 HES1 NR1H2 ZFPM1 SUFU PLK3 SCAF4 KLF2 | 4.17e-05 | 1053 | 79 | 14 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | HJV ZMYND15 TRIM33 FOXP4 CEBPA MED25 PER1 SMARCC2 HES1 NR1H2 ZFPM1 SUFU PLK3 FOXD1 SCAF4 KLF2 | 6.75e-05 | 1399 | 79 | 16 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | HJV ZMYND15 TRIM33 FOXP4 CEBPA MED25 PER1 SMARCC2 HES1 NR1H2 ZFPM1 SUFU PLK3 FOXD1 SCAF4 KLF2 | 7.60e-05 | 1413 | 79 | 16 | GO:1902679 |
| GeneOntologyCellularComponent | chromatin | TRIM33 FOXP4 NEUROD2 CEBPA NKX2-4 CPSF6 KLF14 TPRX1 SMARCC2 IRF5 HES1 NR1H2 ZFPM1 ZBED3 PLK3 RXRB FOXD1 KLF2 | 1.13e-05 | 1480 | 81 | 18 | GO:0000785 |
| GeneOntologyCellularComponent | clathrin-sculpted glutamate transport vesicle membrane | 5.25e-04 | 9 | 81 | 2 | GO:0060203 | |
| GeneOntologyCellularComponent | clathrin-sculpted glutamate transport vesicle | 5.25e-04 | 9 | 81 | 2 | GO:0060199 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 6.59e-04 | 272 | 81 | 6 | GO:0090575 | |
| Domain | WH2 | 2.37e-05 | 14 | 77 | 3 | SM00246 | |
| Domain | WH2 | 3.63e-05 | 16 | 77 | 3 | PF02205 | |
| Domain | WH2_dom | 8.49e-05 | 21 | 77 | 3 | IPR003124 | |
| Domain | WH2 | 1.28e-04 | 24 | 77 | 3 | PS51082 | |
| Domain | SANT_dom | 5.11e-03 | 26 | 77 | 2 | IPR017884 | |
| Domain | Collagen | 5.22e-03 | 85 | 77 | 3 | IPR008160 | |
| Domain | Collagen | 5.22e-03 | 85 | 77 | 3 | PF01391 | |
| Domain | SANT | 5.92e-03 | 28 | 77 | 2 | PS51293 | |
| Domain | VG_K_chnl | 8.15e-03 | 33 | 77 | 2 | IPR028325 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ZXDC FAM193B INTS5 FBRSL1 MED14 PER1 IRF5 ZFPM1 ATG2A DMWD SUFU ZBED3 PRAG1 CNTROB UVRAG TRIB1 PLK3 EML3 CRAMP1 | 6.98e-12 | 1105 | 81 | 19 | 35748872 |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 7.69e-08 | 154 | 81 | 7 | 16055720 | |
| Pubmed | 7.80e-08 | 329 | 81 | 9 | 17474147 | ||
| Pubmed | Genetics of synaptic vesicle function: toward the complete functional anatomy of an organelle. | 1.21e-07 | 5 | 81 | 3 | 10099709 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXP4 NEUROD2 NKX2-4 TPRX1 IRF5 HES1 NR1H2 ZFPM1 ZBED3 CRAMP1 RXRB KLF2 | 1.26e-06 | 908 | 81 | 12 | 19274049 |
| Pubmed | The transcription factor XBP1 is selectively required for eosinophil differentiation. | 1.70e-06 | 37 | 81 | 4 | 26147683 | |
| Pubmed | 3.42e-06 | 13 | 81 | 3 | 14622142 | ||
| Pubmed | FOXD1 is required for 3D patterning of the kidney interstitial matrix. | 3.42e-06 | 13 | 81 | 3 | 36335435 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24486580 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 12437929 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 27011007 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 23630301 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 26752341 | ||
| Pubmed | Tribbles-1 regulates hepatic lipogenesis through posttranscriptional regulation of C/EBPα. | 5.36e-06 | 2 | 81 | 2 | 26348894 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 17419995 | ||
| Pubmed | Identification of a novel DNA binding site for nuclear orphan receptor OR1. | 5.36e-06 | 2 | 81 | 2 | 10187832 | |
| Pubmed | Molecular Mechanism of CCAAT-Enhancer Binding Protein Recruitment by the TRIB1 Pseudokinase. | 5.36e-06 | 2 | 81 | 2 | 26455797 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 15496413 | ||
| Pubmed | TRIB1 regulates LDL metabolism through CEBPα-mediated effects on the LDL receptor in hepatocytes. | 5.36e-06 | 2 | 81 | 2 | 34779419 | |
| Pubmed | Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. | 6.39e-06 | 111 | 81 | 5 | 22558309 | |
| Pubmed | 1.57e-05 | 21 | 81 | 3 | 28794157 | ||
| Pubmed | RXR heterodimers orchestrate transcriptional control of neurogenesis and cell fate specification. | 1.60e-05 | 3 | 81 | 2 | 28778663 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 10087612 | ||
| Pubmed | COP1 targets C/EBPα for degradation and induces acute myeloid leukemia via Trib1. | 1.60e-05 | 3 | 81 | 2 | 23884858 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 10202051 | ||
| Pubmed | Rabphilin regulates SNARE-dependent re-priming of synaptic vesicles for fusion. | 1.60e-05 | 3 | 81 | 2 | 16763567 | |
| Pubmed | WIP provides an essential link between Nck and N-WASP during Arp2/3-dependent actin polymerization. | 1.60e-05 | 3 | 81 | 2 | 23707428 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 31301160 | ||
| Pubmed | Dimerization of the Pragmin Pseudo-Kinase Regulates Protein Tyrosine Phosphorylation. | 1.60e-05 | 3 | 81 | 2 | 29503074 | |
| Pubmed | The WH1 and EVH1 domains of WASP and Ena/VASP family members bind distinct sequence motifs. | 1.60e-05 | 3 | 81 | 2 | 12372256 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 16483316 | ||
| Pubmed | Cdc42 interacts with the exocyst complex to promote phagocytosis. | 1.60e-05 | 3 | 81 | 2 | 23295348 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 21769917 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 24185616 | ||
| Pubmed | 1.76e-05 | 66 | 81 | 4 | 23275444 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.84e-05 | 351 | 81 | 7 | 38297188 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 3.03e-05 | 857 | 81 | 10 | 25609649 | |
| Pubmed | FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors. | 3.20e-05 | 4 | 81 | 2 | 22068055 | |
| Pubmed | WIP regulates N-WASP-mediated actin polymerization and filopodium formation. | 3.20e-05 | 4 | 81 | 2 | 11331876 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 15684033 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 9950691 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 1916105 | ||
| Pubmed | 3.25e-05 | 77 | 81 | 4 | 21525287 | ||
| Pubmed | 3.96e-05 | 268 | 81 | 6 | 33640491 | ||
| Pubmed | 4.08e-05 | 709 | 81 | 9 | 22988430 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 4.59e-05 | 167 | 81 | 5 | 20362541 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 20410507 | ||
| Pubmed | Ligand-dependent contribution of RXRbeta to cholesterol homeostasis in Sertoli cells. | 5.33e-05 | 5 | 81 | 2 | 14993927 | |
| Pubmed | Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway. | 5.33e-05 | 5 | 81 | 2 | 21076395 | |
| Pubmed | Substrate binding allosterically relieves autoinhibition of the pseudokinase TRIB1. | 5.33e-05 | 5 | 81 | 2 | 30254053 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 24698977 | ||
| Pubmed | The pseudokinase TRIB1 toggles an intramolecular switch to regulate COP1 nuclear export. | 5.33e-05 | 5 | 81 | 2 | 30692133 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 22966049 | ||
| Pubmed | FBP11 regulates nuclear localization of N-WASP and inhibits N-WASP-dependent microspike formation. | 5.33e-05 | 5 | 81 | 2 | 14697212 | |
| Pubmed | Early T-cell progenitors are the major granulocyte precursors in the adult mouse thymus. | 5.33e-05 | 5 | 81 | 2 | 23152541 | |
| Pubmed | IL-17 inhibits adipogenesis in part via C/EBPα, PPARγ and Krüppel-like factors. | 5.33e-05 | 5 | 81 | 2 | 23332504 | |
| Pubmed | Hes7: a bHLH-type repressor gene regulated by Notch and expressed in the presomitic mesoderm. | 5.33e-05 | 5 | 81 | 2 | 11260262 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 15492844 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 8552632 | ||
| Pubmed | Homozygous MED25 mutation implicated in eye-intellectual disability syndrome. | 5.33e-05 | 5 | 81 | 2 | 25792360 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | SPTBN4 ZXDC FAM193B NEUROD2 SOBP DAZAP2 HES1 NR1H2 BTBD2 PRAG1 KHSRP | 5.86e-05 | 1124 | 81 | 11 | 21900206 |
| Pubmed | Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. | 6.91e-05 | 34 | 81 | 3 | 20581827 | |
| Pubmed | Wiskott-Aldrich syndrome protein is involved in alphaIIb beta3-mediated cell adhesion. | 7.99e-05 | 6 | 81 | 2 | 16582881 | |
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 19798448 | ||
| Pubmed | Identification of SNAP-47, a novel Qbc-SNARE with ubiquitous expression. | 7.99e-05 | 6 | 81 | 2 | 16621800 | |
| Pubmed | Synaptic assembly of the brain in the absence of neurotransmitter secretion. | 1.12e-04 | 7 | 81 | 2 | 10657302 | |
| Pubmed | 1.12e-04 | 7 | 81 | 2 | 11359932 | ||
| Pubmed | Beta-NAP, a cerebellar degeneration antigen, is a neuron-specific vesicle coat protein. | 1.12e-04 | 7 | 81 | 2 | 7671305 | |
| Pubmed | 1.12e-04 | 7 | 81 | 2 | 26166747 | ||
| Pubmed | 1.12e-04 | 7 | 81 | 2 | 21382013 | ||
| Pubmed | 1.22e-04 | 41 | 81 | 3 | 20889853 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | TRIM33 CPSF6 FBRSL1 PER1 ATG2A DMWD NCKAP5L ZBED3 CNTROB UVRAG | 1.48e-04 | 1038 | 81 | 10 | 26673895 |
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 10381382 | ||
| Pubmed | Molecular determinants of synapsin targeting to presynaptic terminals. | 1.49e-04 | 8 | 81 | 2 | 15071120 | |
| Pubmed | IRSp53 is an essential intermediate between Rac and WAVE in the regulation of membrane ruffling. | 1.49e-04 | 8 | 81 | 2 | 11130076 | |
| Pubmed | A single-cell transcriptomic landscape of cadmium-hindered brain development in mice. | 1.49e-04 | 8 | 81 | 2 | 39147853 | |
| Pubmed | Interaction of WASP/Scar proteins with actin and vertebrate Arp2/3 complex. | 1.49e-04 | 8 | 81 | 2 | 11146629 | |
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 29431742 | ||
| Pubmed | Yap- and Cdc42-dependent nephrogenesis and morphogenesis during mouse kidney development. | 1.72e-04 | 46 | 81 | 3 | 23555292 | |
| Pubmed | Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. | 2.38e-04 | 10 | 81 | 2 | 16751102 | |
| Pubmed | 2.38e-04 | 10 | 81 | 2 | 10662545 | ||
| Pubmed | Increased expression of angiogenic genes in the brains of mouse meg3-null embryos. | 2.38e-04 | 10 | 81 | 2 | 20392836 | |
| Pubmed | 2.38e-04 | 529 | 81 | 7 | 14621295 | ||
| Pubmed | Automated yeast two-hybrid screening for nuclear receptor-interacting proteins. | 2.71e-04 | 133 | 81 | 4 | 15604093 | |
| Pubmed | Novel interactive partners of neuroligin 3: new aspects for pathogenesis of autism. | 2.77e-04 | 54 | 81 | 3 | 25464930 | |
| Pubmed | CIN85 interacting proteins in B cells-specific role for SHIP-1. | 2.77e-04 | 54 | 81 | 3 | 21725061 | |
| Pubmed | 2.77e-04 | 54 | 81 | 3 | 16239144 | ||
| Pubmed | Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis. | 2.91e-04 | 11 | 81 | 2 | 11753414 | |
| Pubmed | mTORC1 activity is essential for erythropoiesis and B cell lineage commitment. | 2.91e-04 | 11 | 81 | 2 | 31729420 | |
| Pubmed | Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis. | 2.91e-04 | 11 | 81 | 2 | 12037571 | |
| Pubmed | 2.91e-04 | 11 | 81 | 2 | 21293061 | ||
| Pubmed | 2.91e-04 | 11 | 81 | 2 | 18003620 | ||
| Pubmed | BCL9L REEP1 AP2A2 CPSF6 VAMP2 PER1 SMARCC2 RPH3A SHANK3 KHSRP | 3.12e-04 | 1139 | 81 | 10 | 36417873 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 3.41e-04 | 398 | 81 | 6 | 35016035 | |
| Pubmed | 3.48e-04 | 12 | 81 | 2 | 15589691 | ||
| Pubmed | 3.48e-04 | 12 | 81 | 2 | 23563140 | ||
| Pubmed | Ptch1 is essential for cochlear marginal cell differentiation and stria vascularis formation. | 3.48e-04 | 12 | 81 | 2 | 38602877 | |
| Pubmed | 3.48e-04 | 12 | 81 | 2 | 35192416 | ||
| Pubmed | A novel docking site on Mediator is critical for activation by VP16 in mammalian cells. | 4.11e-04 | 13 | 81 | 2 | 14657022 | |
| Pubmed | 4.11e-04 | 13 | 81 | 2 | 29898395 | ||
| Interaction | TOP3B interactions | ZXDC FAM193B INTS5 FBRSL1 MED14 PER1 IRF5 ZFPM1 ATG2A DMWD SUFU ZBED3 PRAG1 CNTROB UVRAG TRIB1 PLK3 EML3 CRAMP1 | 2.33e-06 | 1470 | 78 | 19 | int:TOP3B |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 9.16e-05 | 797 | 82 | 8 | chr19p13 | |
| Cytoband | 19q13.3 | 4.39e-04 | 82 | 82 | 3 | 19q13.3 | |
| Cytoband | 19p13.3 | 8.84e-04 | 237 | 82 | 4 | 19p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 9.89e-04 | 423 | 82 | 5 | chr12q13 | |
| Cytoband | 17p13.1 | 1.26e-03 | 118 | 82 | 3 | 17p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 1.32e-03 | 1192 | 82 | 8 | chr19q13 | |
| Cytoband | 12q13.12 | 2.12e-03 | 38 | 82 | 2 | 12q13.12 | |
| Cytoband | 11q12.3 | 2.12e-03 | 38 | 82 | 2 | 11q12.3 | |
| Cytoband | 12q12 | 3.23e-03 | 47 | 82 | 2 | 12q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 3.49e-03 | 346 | 82 | 4 | chr17p13 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 9.13e-04 | 16 | 51 | 2 | 14 | |
| GeneFamily | Zinc fingers C2H2-type|Kruppel like factors | 1.16e-03 | 18 | 51 | 2 | 624 | |
| Coexpression | GSE23925_DARK_ZONE_VS_NAIVE_BCELL_DN | 2.47e-06 | 200 | 79 | 7 | M7881 | |
| Coexpression | TRAVAGLINI_LUNG_NEUTROPHIL_CELL | 1.47e-05 | 366 | 79 | 8 | M41688 | |
| Coexpression | STARK_HYPPOCAMPUS_22Q11_DELETION_UP | 2.00e-05 | 53 | 79 | 4 | MM582 | |
| Coexpression | STARK_HYPPOCAMPUS_22Q11_DELETION_UP | 2.16e-05 | 54 | 79 | 4 | M12050 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP | 3.03e-05 | 198 | 79 | 6 | M5293 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-06 | 186 | 82 | 6 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-06 | 189 | 82 | 6 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | PBMC-Severe-cDC_5|Severe / Compartment, Disease Groups and Clusters | 1.59e-06 | 194 | 82 | 6 | b903e23eb75733ca516770727097fe74a9f8c1d1 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l33|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.31e-06 | 136 | 82 | 5 | a43b3db1754c619d328a26a2ba6af4756629a723 | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Spindle_Cell-1|TCGA-Uvea / Sample_Type by Project: Shred V9 | 1.48e-05 | 168 | 82 | 5 | b427746929bb40e3d1b5f1c40d302b792d6b32a5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.52e-05 | 169 | 82 | 5 | 0867528101767fc65e93b3561480bf830c50368d | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 172 | 82 | 5 | cfcfa7eeff1805bedf10a3c07826459914c3e872 | |
| ToppCell | PBMC-Mild-cDC_8|Mild / Compartment, Disease Groups and Clusters | 2.35e-05 | 185 | 82 | 5 | 891b39c20fe9858fbba90d9ef7a253f1a0870211 | |
| ToppCell | 18-Airway-Epithelial-Basal_cell|Airway / Age, Tissue, Lineage and Cell class | 2.88e-05 | 193 | 82 | 5 | 5067b0db24f96e26cf3f9437736415f694e7a614 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 194 | 82 | 5 | 550e61a40be2baa59520aaf5912bb99ad094ba15 | |
| ToppCell | wk_20-22|World / Celltypes from embryonic and fetal-stage human lung | 3.25e-05 | 198 | 82 | 5 | 56eb765773a1a27a44262a447df7cfae8a9db90d | |
| ToppCell | Severe-B_memory-0|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.25e-05 | 198 | 82 | 5 | 9cc75d14f1220fe15e530115f6dff09c31f07f7c | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.41e-05 | 200 | 82 | 5 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.41e-05 | 200 | 82 | 5 | 80e0483d5ab0c6213aae0ec62619f57e6ec0e4c2 | |
| ToppCell | TCGA-Ovary-Primary_Tumor|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.42e-05 | 106 | 82 | 4 | 14f548be39cec604fbdae0382cbf434fa4049840 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.42e-05 | 106 | 82 | 4 | 939b80950d39cdc7149a05fdfb64c8810064cdb1 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.42e-05 | 106 | 82 | 4 | e9e1b55f32b3d5b9eeec94a997912e5c21c1fb48 | |
| Drug | Cytisine (-) [485-35-8]; Down 200; 21uM; MCF7; HT_HG-U133A | 4.20e-07 | 197 | 79 | 8 | 6217_DN | |
| Drug | Oxamniquine [21738-42-1]; Down 200; 14.4uM; PC3; HT_HG-U133A | 5.78e-06 | 198 | 79 | 7 | 4006_DN | |
| Drug | Diprophylline [479-18-5]; Up 200; 15.8uM; PC3; HT_HG-U133A | 5.97e-06 | 199 | 79 | 7 | 1811_UP | |
| Drug | fullerene C60 | HJV ZXDC NEUROD2 CEBPA CASKIN2 VAMP2 PER1 SYN1 KCNQ1 ZFPM1 BTBD2 ARHGAP27 BCAR1 TRIB1 PLK3 SHANK3 RXRB | 1.19e-05 | 1498 | 79 | 17 | ctd:C069837 |
| Drug | AC1L1HRY | 1.80e-05 | 45 | 79 | 4 | CID000004265 | |
| Drug | N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE | 3.56e-05 | 3 | 79 | 2 | DB07080 | |
| Drug | Cantharidin [56-25-7]; Down 200; 20.4uM; HL60; HT_HG-U133A | 4.79e-05 | 187 | 79 | 6 | 3075_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 4.93e-05 | 188 | 79 | 6 | 986_DN | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 5.39e-05 | 191 | 79 | 6 | 3890_DN | |
| Drug | Zardaverine [101975-10-4]; Up 200; 15uM; MCF7; HT_HG-U133A | 5.87e-05 | 194 | 79 | 6 | 7347_UP | |
| Drug | Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 5.87e-05 | 194 | 79 | 6 | 4804_DN | |
| Drug | Minocycline hydrochloride [13614-98-7]; Down 200; 8uM; PC3; HT_HG-U133A | 6.04e-05 | 195 | 79 | 6 | 5077_DN | |
| Drug | Lumicolchicine gamma [6901-14-0]; Up 200; 10uM; HL60; HT_HG-U133A | 6.22e-05 | 196 | 79 | 6 | 1317_UP | |
| Drug | Thiethylperazine malate [52239-63-1]; Down 200; 6uM; MCF7; HT_HG-U133A | 6.40e-05 | 197 | 79 | 6 | 6232_DN | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 6.40e-05 | 197 | 79 | 6 | 2641_DN | |
| Drug | Pergolide mesylate [66104-23-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 6.58e-05 | 198 | 79 | 6 | 7031_DN | |
| Drug | Diprophylline [479-18-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 6.58e-05 | 198 | 79 | 6 | 1689_UP | |
| Disease | basophil percentage of granulocytes | 7.45e-05 | 83 | 79 | 4 | EFO_0007995 | |
| Disease | hypertension | 1.78e-04 | 307 | 79 | 6 | EFO_0000537 | |
| Disease | free cholesterol to total lipids in very large HDL percentage | 4.38e-04 | 55 | 79 | 3 | EFO_0022288 | |
| Disease | tumor necrosis factor receptor superfamily member EDAR measurement | 4.59e-04 | 12 | 79 | 2 | EFO_0008310 | |
| Disease | dickkopf‐related protein 1 measurement | 4.59e-04 | 12 | 79 | 2 | EFO_0010620 | |
| Disease | vascular endothelial growth factor measurement | 4.62e-04 | 56 | 79 | 3 | EFO_0004762 | |
| Disease | non-high density lipoprotein cholesterol measurement | 6.44e-04 | 713 | 79 | 8 | EFO_0005689 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 8.57e-04 | 274 | 79 | 5 | EFO_0004530, EFO_0004612 | |
| Disease | high density lipoprotein particle size measurement | 1.14e-03 | 170 | 79 | 4 | EFO_0008592 | |
| Disease | Meningioma | 1.18e-03 | 19 | 79 | 2 | C0025286 | |
| Disease | C-reactive protein measurement | ZDHHC18 LRFN2 SMARCC2 IRF5 ZFPM1 PRAG1 UVRAG TRIB1 EML3 SCAF4 | 1.40e-03 | 1206 | 79 | 10 | EFO_0004458 |
| Disease | Agents acting on the renin-angiotensin system use measurement | 2.08e-03 | 335 | 79 | 5 | EFO_0009931 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AAPAGEGGPPAPPPN | 11 | P63027 | |
| PPTPGQPAAPPGSQG | 521 | Q8N944 | |
| SPAPHAAPCPGPPPG | 266 | Q9HCM7 | |
| PAGPGPGPPATPAQP | 71 | P56945 | |
| GPGPAPPATQSSPGP | 251 | A6NKF2 | |
| GPDGAPASVPPFPPG | 41 | Q86Z23 | |
| PQPPQPPPGPASASG | 56 | Q09019 | |
| PGAAGPASSPPPAGP | 71 | Q09019 | |
| PASSPPPAGPGPGPA | 76 | Q09019 | |
| SGAPPPSPPVGGPAG | 1321 | Q2TAZ0 | |
| AAPPAPAGPPPSSGG | 666 | O94973 | |
| APPPPRGPALPGAGS | 126 | Q6ZVN8 | |
| PPAGGSPAPPGPAPA | 81 | Q16676 | |
| TAGNIPPPPPGCPPN | 121 | Q15038 | |
| PGAPGPAPPASPAAP | 56 | P51787 | |
| PGQAGPQPPAPTPAP | 296 | Q9H2Z4 | |
| PSRPSPTPQGPPFGG | 1276 | Q9HCH0 | |
| PGGAPGPSVPLPPSQ | 406 | O43292 | |
| APPQPPTPSGGGCSP | 106 | A5PLN7 | |
| PGANATAPPGDPPPG | 51 | A0A1B0GVG4 | |
| PSPGPPQHRPCPGPS | 26 | O15534 | |
| LQPPGPPGSPGPHAP | 336 | Q6ZS72 | |
| AAGAPPPPPPGHAPA | 751 | Q8IX07 | |
| GPPGAPKPPPASQPS | 331 | Q71SY5 | |
| AQPPPGAPQGPPGAA | 611 | Q71SY5 | |
| GAPQGPPGAASGPPP | 616 | Q71SY5 | |
| GPPLGAPNPSASGPP | 651 | Q8IVH2 | |
| GGSPGGAQPPSPVPP | 501 | Q96KJ4 | |
| GAQPPSPVPPGGAPV | 506 | Q96KJ4 | |
| DPSPLAPPPGNPAGF | 196 | Q13568 | |
| PGGSNPAHPPPINPP | 21 | Q9NZ81 | |
| CPPPPGAPHGNPAFP | 41 | Q9NZ81 | |
| PAGSPPASPGPQGPS | 566 | Q3MIN7 | |
| GSPSSPAPGPPPGAP | 761 | Q8WXE0 | |
| AGPSEPPGPPAPAGP | 911 | Q8WXE0 | |
| SGGPPSAPAPPPPGA | 21 | O60244 | |
| PGMQAPGPPPSDPGA | 231 | Q8IYS5 | |
| GASAGPGPPLPPARP | 146 | I0J062 | |
| AGPGGPPPPFPAGQT | 221 | Q16630 | |
| PPPPPSLEAGAGAGP | 31 | Q96PV7 | |
| GAGPAQPPAPPAAPE | 36 | P49715 | |
| ADGPPAPPGAPQAPS | 56 | Q96RY5 | |
| PPPPPQGSGPGISNS | 1126 | Q86UU0 | |
| ALPGPGPPGPASVPQ | 51 | Q8TD94 | |
| SPGPPGLSNGPPAPQ | 96 | Q32P44 | |
| AAAAPGPTPPAPPGP | 51 | Q9BX70 | |
| ASPPPPQAPFGFPGD | 311 | O95104 | |
| DTGPAGPPGPPGAPA | 1476 | P25940 | |
| GPPGPAGNPGPSPNS | 256 | Q96A83 | |
| NPPAPPAGPSSPGPQ | 576 | Q8N137 | |
| PGPGGPQHAPFAPPP | 171 | Q14469 | |
| APFPPSGPSCPPPGG | 86 | Q8NDC0 | |
| SGPSCPPPGGPYPAP | 91 | Q8NDC0 | |
| QPPGPVPGPAPAPAA | 586 | Q92945 | |
| GAPGREPPASPAPPG | 171 | A0A1W2PRP0 | |
| PPPPPGAHSPGATPG | 31 | P17600 | |
| SVGGPVPQPPPGPAA | 6 | Q9P2Y5 | |
| PSAPGPGPAPCTGGP | 271 | Q9UGK3 | |
| PASAPAPGPSAGPPP | 101 | Q9UPN9 | |
| APGPSAGPPPGPPAS | 106 | Q9UPN9 | |
| PAPPQPGQPGTPGGS | 286 | Q9Y2J0 | |
| TPLPGNGPPQPGAPS | 11 | P55055 | |
| GNPAAAAPPGPHPSP | 71 | Q6ZUM4 | |
| GDGAPAPSGPPPPGS | 161 | Q9H902 | |
| DPPGAPGPPGPAPAT | 6 | Q6P9B9 | |
| PGPPGPAPATHGPAP | 11 | Q6P9B9 | |
| PPGSQPIPPTGAAGP | 966 | Q8TAQ2 | |
| GSPGLPPPAPPGFSG | 141 | P28702 | |
| AAPPNAPGGPPGPQP | 101 | Q96RK1 | |
| APGGPPGPQPAPSAA | 106 | Q96RK1 | |
| AGSSPPAAPCPPPPG | 106 | Q96IU2 | |
| AAAAPAPPAGPGPPP | 16 | Q9H4B4 | |
| APPAGPGPPPSALRG | 21 | Q9H4B4 | |
| PISGPFSGPNPGPIP | 166 | Q8N7U7 | |
| GPSGPAAPPGPGVAP | 111 | Q2QGD7 | |
| PCSPQPPPAAPGAGG | 66 | Q96RU8 | |
| PLPSPASGPGPGAPG | 1641 | Q9BYB0 | |
| PPPGGPRNLGPTSSP | 436 | A7XYQ1 | |
| QGTQAGPPPAPPGLP | 31 | O43278 | |
| PGQRGPPSPGPAAQP | 6 | Q9NZV5 | |
| PSGAPGPTAPPAPGP | 6 | Q9UMX1 | |
| APAQGGSAPAPPPPP | 2401 | Q9H254 | |
| RQPSPGPTPPPFPGN | 211 | O43516 | |
| GPGPAPAPAPAPAPA | 1161 | Q86YV5 | |
| GPPPPPFTGADGQPA | 401 | Q9Y6W5 | |
| PAAPSPPAAPGPRGG | 171 | Q4KMQ1 | |
| NSGPPPPPARGRGAP | 296 | O00401 | |
| EPGPAGAPSPAPGAP | 311 | Q9GZT5 | |
| QGSGARPAPGPPPPS | 701 | Q9H091 | |
| GPAASPTPGPGPAPP | 26 | Q9NUE0 | |
| APGPRASFPPPFGGP | 186 | Q9Y5W3 | |
| PGPAASPAGPPAPRG | 46 | Q14003 | |
| PPSSAPAGAPPQGPP | 586 | Q9ULH4 | |
| PPAPGPGAPGPARAA | 41 | Q15784 |